{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:26Z","timestamp":1791352286068,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.2515\/therapie\/2015026","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T06:33:33Z","timestamp":1433745213000},"page":"425-432","source":"Crossref","is-referenced-by-count":24,"title":["Drug-induced Depression: a Case\/Non Case Study in the French Pharmacovigilance Database"],"prefix":"10.1016","volume":"70","author":[{"given":"Claire","family":"Lafay-Chebassier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chavant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Favreli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pizzoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"P\u00e9rault-Pochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.2515\/therapie\/2015026_bb0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.31887\/DCNS.2011.13.1\/ccelano","article-title":"Depressogenic effects of medications: a review","volume":"13","author":"Celano","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0360","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjopharm.2005.09.014","article-title":"Update on drug-induced depression in the elderly","volume":"3","author":"Kotlyar","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"issue":"8463","key":"10.2515\/therapie\/2015026_bb0365","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(85)90918-3","article-title":"Adverse drug reaction monitoring: doing it the French way","volume":"2","author":"Moore","year":"1985","journal-title":"Lancet"},{"issue":"2","key":"10.2515\/therapie\/2015026_bb0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"6","key":"10.2515\/therapie\/2015026_bb0375","first-page":"507","article-title":"Drug-induced dementia: a case\/non-case study in the French Pharmacovigilance database","volume":"62","author":"Favreliere","year":"2007","journal-title":"Therapie"},{"issue":"5","key":"10.2515\/therapie\/2015026_bb0380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","article-title":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/non-case study in the French pharmacovigilance system database","volume":"44","author":"Moore","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1469-1809.1955.tb01348.x","article-title":"On estimating the relation between blood group and disease","volume":"19","author":"Woolf","year":"1955","journal-title":"Ann Hum Genet"},{"issue":"Suppl 6","key":"10.2515\/therapie\/2015026_bb0390","first-page":"S13","article-title":"The current state of mental health surveillance in France","volume":"23","author":"Chan Chee","year":"2011","journal-title":"Sante Publique"},{"issue":"7","key":"10.2515\/therapie\/2015026_bb0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula","year":"2007","journal-title":"Drug Saf"},{"issue":"2","key":"10.2515\/therapie\/2015026_bb0400","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pbb.2006.01.010","article-title":"Antinociceptive and behavioral effects of ribavirin in mice","volume":"83","author":"Abdel-Salam","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.2515\/therapie\/2015026_bb0405","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4088\/JCP.08m04441","article-title":"Varenicline augmentation in depressed smokers: an 8-week, open-label study","volume":"70","author":"Philip","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1-3","key":"10.2515\/therapie\/2015026_bb0410","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline\u2019s effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0415","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.euroneuro.2014.01.016","article-title":"Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study","volume":"24","author":"Ng","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"10.2515\/therapie\/2015026_bb0420","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0269881111421975","article-title":"Reconsidering GHB: orphan drug or new model antidepressant?","volume":"26","author":"Bosch","year":"2012","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.PSY.0000041544.14277.EC","article-title":"Major depression, physical illness, and suicidal ideation in primary care","volume":"65","author":"Goodwin","year":"2003","journal-title":"Psychosom Med"},{"issue":"1","key":"10.2515\/therapie\/2015026_bb0430","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood-brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.2515\/therapie\/2015026_bb0435","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bcpt.12037","article-title":"Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress","volume":"112","author":"Karson","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"10.2515\/therapie\/2015026_bb0440","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00296-010-1616-x","article-title":"Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level","volume":"32","author":"Ertenli","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.2515\/therapie\/2015026_bb0445","series-title":"Neuroprotective Mechanisms of Nevirapine and Efavirenz in Model of Neurodegeneration","author":"Zheve","year":"2008"},{"issue":"5","key":"10.2515\/therapie\/2015026_bb0450","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/appi.psy.49.5.442","article-title":"Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders","volume":"49","author":"Schaefer","year":"2008","journal-title":"Psychosomatics"},{"issue":"3","key":"10.2515\/therapie\/2015026_bb0455","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3181\/0706-MR-158","article-title":"Retinoid-mediated regulation of mood: possible cellular mechanisms","volume":"233","author":"O\u2019Reilly","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"10.2515\/therapie\/2015026_bb0460","first-page":"367","article-title":"The serotonin syndrome: initial misdiagnosis","volume":"11","author":"Attar-Herzberg","year":"2009","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0465","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ph4040603","article-title":"Role of 5-HT3 receptors in the antide-pressant response","volume":"4","author":"Betry","year":"2011","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.2515\/therapie\/2015026_bb0470","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000087107","article-title":"Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats","volume":"12","author":"O\u2019Mahony","year":"2005","journal-title":"Neuroimmunomodulation"},{"issue":"9","key":"10.2515\/therapie\/2015026_bb0475","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.2515\/therapie\/2015026_bb0480","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biopsych.2009.05.031","article-title":"The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders","volume":"66","author":"Chen","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.2515\/therapie\/2015026_bb0485","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S1461145710000830","article-title":"Depressive symptoms following interferon-alpha therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?","volume":"14","author":"Kenis","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"14","key":"10.2515\/therapie\/2015026_bb0490","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.0306336101","article-title":"13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice","volume":"101","author":"Crandall","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.2515\/therapie\/2015026_bb0495","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(81)90012-3","article-title":"Physostigmine induction of depressive symptomatology in normal human subjects","volume":"4","author":"Risch","year":"1981","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.2515\/therapie\/2015026_bb0500","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-0327(95)00025-I","article-title":"GABA and mood disorders: a brief review and hypothesis","volume":"34","author":"Petty","year":"1995","journal-title":"J Affect Disord"},{"issue":"1","key":"10.2515\/therapie\/2015026_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.01004.x","article-title":"The GABAB receptor as a target for antidepressant drug action","volume":"162","author":"Ghose","year":"2010","journal-title":"Br J Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716310873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T20:24:32Z","timestamp":1652300672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716310873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0040595716310873"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2015026","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}